Taurine and hypotaurinemetabolism

Taurine and hypotaurinemetabolism (CAS No.: 345909-26-4) represents a bile acid–related taurine conjugate commonly classified within bile salt derivatives that play a central role in lipid emulsification and transport processes. This compound facilitates the formation of micellar structures during lipid digestion, thereby increasing the effective surface area of lipids and enhancing enzymatic hydrolysis by lipases, which makes it a valuable reagent for studying lipid metabolism and absorption mechanisms. In biological systems, it is associated with pathways involving bile acid signaling and taurine metabolism, and has been reported to modulate processes such as vascular endothelial growth factor A expression and immune-related signaling, suggesting relevance to hepatobiliary and inflammatory response models. In vitro, it is frequently applied in cell-based assays and organoid culture systems to improve the solubility and bioavailability of hydrophobic compounds, typically demonstrating activity within low micromolar to millimolar concentration ranges depending on the assay context. It is also widely used in the establishment of intestinal absorption models and experimental pancreatitis or bile duct injury models to investigate drug transport, metabolism, and lipid-associated physiological responses. Experimental concentrations and dosing regimens vary according to specific study designs, emphasizing its role as a versatile tool compound in biomedical research and drug discovery focused on lipid handling, bile acid biology, and metabolic regulation.